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Abstract
Background: In Australia and internationally, there is concern about the growing proportion of women giving birth by
caesarean section. There is evidence of increased risk of placenta accreta and percreta in subsequent pregnancies as well as
decreased fertility; and significant resource implications. Randomised controlled trials (RCTs) of continuity of midwifery care
have reported reduced caesareans and other interventions in labour, as well as increased maternal satisfaction, with no
statistically significant differences in perinatal morbidity or mortality. RCTs conducted in the UK and in Australia have largely
measured the effect of teams  of care providers (commonly 6–12 midwives) with very few testing caseload (one-to-one)
midwifery care. This study aims to determine whether caseload (one-to-one) midwifery care for women at low risk of medical
complications decreases the proportion of women delivering by caesarean section compared with women receiving 'standard'
care. This paper presents the trial protocol in detail.
Methods/design: A two-arm RCT design will be used. Women who are identified at low medical risk will be recruited from
the antenatal booking clinics of a tertiary women's hospital in Melbourne, Australia. Baseline data will be collected, then women
randomised to caseload midwifery or standard low risk care. Women allocated to the caseload intervention will receive
antenatal, intrapartum and postpartum care from a designated primary midwife with one or two antenatal visits conducted by
a 'back-up' midwife. The midwives will collaborate with obstetricians and other health professionals as necessary. If the woman
has an extended labour, or if the primary midwife is unavailable, care will be provided by the back-up midwife. For women
allocated to standard care, options include midwifery-led care with varying levels of continuity, junior obstetric care and
community based general medical practitioner care. Data will be collected at recruitment (self administered survey) and at 2
and 6 months postpartum by postal survey. Medical/obstetric outcomes will be abstracted from the medical record. The sample
size of 2008 was calculated to identify a decrease in caesarean birth from 19 to 14% and detect a range of other significant clinical
differences. Comprehensive process and economic evaluations will be conducted.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN012607000073404.
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Background
Continuity of carer in the provision of maternity care has
been strongly recommended and encouraged in Victoria
and throughout Australia. The Victorian Department of
Human Services (DHS) released a policy document
"Future directions for Victoria's maternity services" [1] in
June 2004 which endorsed and promoted the expansion
of public models of maternity care that offer continuity of
carer. Many hospitals have responded by introducing
caseload midwifery, a one to one midwifery model of care
in which women are cared for by a primary midwife
throughout pregnancy, birth and the early postnatal
period; a model of care that has been subjected to very lit-
tle rigorous evaluation. We know of only two randomised
controlled trials (RCTs) of caseload midwifery care; both
conducted in the United Kingdom in the1990s [2,3]. One
did not include an 'on call' component for midwives [2],
whereby midwives are called in to work when a woman in
their caseload requires labour care. This aspect is likely to
have a significant impact on midwives' lives and has been
a common component of the model when implemented
in Australia. The other was a cluster trial, with all mid-
wives attached to between one and three general medical
practices [3] – a very different system of maternity care
than that available in Australia. Other evaluations of the
caseload model have used comparative descriptive
designs, with most arguing that for feasibility and practi-
cal reasons using an RCT design was not possible [4-6].
There have been no RCTs of caseload midwifery care in
Australia.
There is evidence from RCTs that continuity of midwifery
care may lead to reduced caesarean sections [7,8] and
instrumental vaginal births [9], and a decrease in other
interventions during labour including induction [3,9]
augmentation [9] analgesia use [9] and episiotomy
[10,11]. One Australian RCT demonstrated a decrease in
women having caesarean birth from 18% to 13% [7].
Many of these RCTs have also reported increased satisfac-
tion for women [11-14], with no statistically significant
differences in perinatal morbidity or mortality [9,15].
RCTs of continuity of midwifery care in the UK and in
Australia have largely measured the effect of teams of care
providers (commonly 6–12 midwives). Caseload mid-
wifery care differs in that women are cared for by a primary
midwife throughout pregnancy, birth and the early post-
natal period. The underlying philosophy is one of conti-
nuity of carer for both women and midwives. The primary
midwife is on call for labour and birth care for the women
in her caseload. One or two other midwives are intro-
duced during pregnancy in case they are needed as a back-
up, for example if the primary midwife has two women in
labour at the same time, if a woman's labour is quite
extended or if the primary midwife is on days rostered 'off
call' or leave when labour begins. A fulltime midwife usu-
ally cares for 40–45 women per year [16].
The impact of the caseload midwifery model on staff
retention and attrition is unknown, but is another impor-
tant issue for consideration in light of the fact that a 2002
review of the midwifery workforce in Australia concluded
that there is a national shortage of midwives that is
expected to increase over the next few years [17]. It is pos-
sible that the continuity inherent in caseload midwifery
and potential for lower intervention childbirth would
improve midwife satisfaction [18-21]; however studies in
the UK and Australia have reported problems with the
widespread implementation and organisation of models
that promote continuity of carer. Issues for midwives
include high and unsustainable workloads, personal costs
(impinging on family life) [22,23]; and burnout and
stress [24]. A caseload model in Sydney ceased operations
in 2001 following "many stressors from within and
beyond the partnership model" [[5], p34]. In response to
these issues, some organisations have altered their
approach, and moved from a caseload model to mid-
wifery teams [25]. A 2000 review of continuity of carer
models concluded that services should be organised in a
way that aims to put less strain on midwives' lives [26].
Conflict between midwives working in new models and
the staff in traditional models has also been reported
[27,28]. Midwives in new models, or the new models
themselves, may be seen as a threat by medical staff, in
that the midwives may be taking on work otherwise done
by them [21]. In a qualitative evaluation of a team mid-
wifery model in Brisbane, midwives were surprised by the
lack of support from other staff, both peers and adminis-
trators [27]. In two other trials it was reported that team
midwives had to frequently respond to criticisms about
their role or work practices [28]. In a setting of midwifery
workforce shortages it is critical that the impact of new
models of care is properly evaluated with regard to mid-
wife job satisfaction, recruitment and retention.
There is a lack of evidence regarding the safety and the effi-
cacy of the caseload model, although the existing RCTs of
midwifery care (mostly team midwifery) do report
decreases in interventions in labour and birth. In Victoria
in 2004, 30% of births were by caesarean; a rate that has
almost doubled over the past 20 years [29]. Reports in the
USA and Australia have shown that the increase is related
partly to non-clinical factors such as demographics, physi-
cian practice patterns, and maternal choice [30-34]. In
Australia, intervention rates are highest among women
with private health insurance, women giving birth in
major tertiary hospitals and women attended by specialist
obstetricians [34], and there is a particular concern with
the high rate of elective caesarean section where there is
no medical indication, and a recommendation that thereBMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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should be national leadership to reduce caesarean section
rates [34]. It is timely that an RCT be undertaken to test
the safety of the caseload model and to ascertain the effect
of caseload midwifery on the rate of caesarean section
births.
There is increasing evidence that a caesarean section has
implications for subsequent pregnancies, including
increased risk of placenta accreta and percreta [35];
decreased fertility [36-40]; and an increased risk of ectopic
pregnancy and spontaneous abortion [41]. Evidence
around the protective effect (or otherwise) of caesarean
section on urinary and faecal incontinence is inconsistent
and likely to be multifactorial. There is some evidence of
increased neonatal respiratory morbidity for babies born
by caesarean section [42,43], however the frequency of
significant fetal injury may be greater with vaginal delivery
[44]. There are also significant resource implications: the
increasing caesarean section rate adds an economic bur-
den to already under-resourced medical systems [45].
Significant questions remain regarding the safety and effi-
cacy of the caseload model, as well as its sustainability, the
impact on the workforce, and costs of the model, given
how different caseload is to a model using a team of mid-
wives. There have been few economic evaluations of mid-
wifery models of care. Published studies have reported
conflicting results: some have reported continuity of care
to be more expensive [46] and others that continuity
models are more cost effective [14,47], although the stud-
ies used different methods to calculate costs.
It is not clear whether continuity of carer per se is more
important to women than consistent and personalised
care, even if it is provided by a number of care-givers
[26,48].
We plan to implement a caseload midwifery model under
RCT conditions to evaluate its effect on the rate of caesar-
ean section and on a range of significant secondary out-
comes. This paper describes the trial protocol in detail.
Methods/design
The study uses a two arm, unblinded randomised control-
led design, stratified by parity, to compare caseload mid-
wifery care with standard maternity care.
Aims
This study aims to determine whether caseload (one to
one) midwifery care for women at low risk of medical
complications decreases the proportion of women deliv-
ering by caesarean section compared with women receiv-
ing 'standard' care. The primary hypothesis is that:
Women randomised to caseload midwifery care will have
5% fewer caesarean section births than women in stand-
ard care model, that is, 14% versus 19%.
Secondary aims of the study are to compare caseload mid-
wifery and standard care with regard to differences in:
a) Maternal outcomes
- instrumental vaginal births, obstetric analgesia, perineal
trauma, and induction of labour;
- postnatal depression;
- satisfaction with care;
- breastfeeding duration;
- smoking cessation.
b) Midwife outcomes (compared to midwives providing
standard care)
- staff attrition from the model of care and the hospital;
- work satisfaction;
- burnout.
c) Costs and cost effectiveness
A final aim is to collect data on maternal and perinatal
morbidity and mortality for inclusion in meta-analyses
(the sample size will be insufficient to determine statisti-
cal differences). These include measures of perinatal mor-
bidity and mortality and maternal mortality and
morbidity.
Comprehensive process evaluation will be undertaken to
explore sustainability issues and to assess intervention
compliance.
Outcome variables
Primary outcome
The principal outcome of the study is the proportion of
women having a caesarean section birth.
For the secondary aims of the study the following varia-
bles will be collected:
a) Instrumental vaginal births
b) Obstetric analgesia
c) Perineal traumaBMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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d) Induction of labour and augmentation of labour
e) Satisfaction with care
f) Proportion of women breastfeeding to two and six
months
g) Postnatal depression
h) Smoking
i) Costs
j) Staff attrition and satisfaction
Other related outcomes
measures of perinatal morbidity and mortality (e.g. fetal
or neonatal death, intraventricular haemorrhage, necrotis-
ing enterocolitis, sepsis, severe respiratory distress syn-
drome, special care nursery admissions; Apgar scores,
seizures); and maternal morbidity and mortality (e.g.
postpartum haemorrhage, eclampsia, postpartum
pyrexia, pulmonary embolus).
Study population
Women attending for a booking visit at the antenatal
clinic of a tertiary maternity hospital in Melbourne, Aus-
tralia during the recruitment period and who are identi-
fied as being at low medical risk will be approached to
participate in the trial.
Inclusion criteria
- English-speaking: able to speak, read and write in Eng-
lish;
- Less than 24 completed weeks gestation at recruitment;
- Low-medical risk at recruitment (list below);
- Singleton pregnancy.
Exclusion criteria
- Planned, elective caesarean section
- Considered to be at increased medical or obstetric risk
according to the following criteria:
Medical criteria
❍ Age > 42 years (subject to medical review)
❍ Alcohol or drug abuse
❍ History of anaesthetic difficulties (subject to medical
review)
❍ Anaemia (< 90 g/l not responding to treatment)
❍ Asthma and/or chronic bronchitis (poorly controlled
or requiring hospitalisation in the last 12 months)
❍ Autoimmune diseases (includes antiphospholipid anti-
bodies)
❍ Bleeding disorders and/or haemolytic disease
❍ Body mass index ≥ 35 or < 17
❍ Cardiac disease
❍ Diabetes mellitus
❍ Endocrine disorders
❍ Epilepsy requiring anticonvulsants in the previous
twelve months
❍ Gastrointestinal disorders (subject to medical review)
❍ Haemoglobinopathy (major)
❍ HIV positive status
❍ Hypertension
❍ Infectious disease (e.g. Acute Hepatitis C)
❍ Neurological disorders
❍ Severe psychiatric illness (subject to psychiatric advice)
❍ Physical disability (e.g. paraplegia)
❍ Renal disease
❍ Respiratory disease (chronic/disabling)
❍ Thromboembolic disease
❍ Thyroid disease (uncontrolled)
Obstetric/gynaecological criteria
❍ Birthweight of previous baby < 2500 g or > 4500 g (sub-
ject to medical review)
❍ Significant cervical conditions (e.g. previous cone
biopsy)
❍ Fetal abnormality requiring specialised neonatal care
❍ Previous mid trimester loss (× 2)BMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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❍ Multiple pregnancy
❍ Parity ≥ 5 (subject to medical review)
❍ Placental abruption (previous significant)
❍ Previous significant postpartum haemorrhage (subject
to medical review)
❍ Pre-eclampsia (previous)
❍ Puerperal psychosis (previous)
❍ Recurrent miscarriage (× 3)
❍ Rhesus isoimmunisation or other significant blood
group antibodies
❍ Previous stillbirth (not due to congenital malforma-
tion)
❍ Uterine surgery (e.g. previous caesarean section)
❍ Uterine myoma or malformation (subject to medical
review)
Sample size
Initial power calculations were based on the caesarean
section rate for women who were low risk at booking at
the Royal Women's hospital in 2005, i.e. 19%. It was
hypothesised that the caseload model of care would
decrease the caesarean section rate from 19% to 14%. In
order to detect such a difference (with 80% power and
95% confidence) we needed 904 women in each trial arm.
Allowing for 10% loss to follow up, 1004 women in each
group were required, i.e. a total sample of 2008. This sam-
ple size also enables the detection of a range of other sta-
tistically significant differences to be detected for the
major secondary outcomes, as shown in Table 1.
Recruitment of women to the trial
Recruitment to the trial will take place in the antenatal
clinic when women attend for their maternity booking
visit.
Participant information
Women will be sent written information (a brochure)
about the study when they ring to book into the hospital
for their pregnancy care (see Additional file 1). A partici-
pant information sheet and another copy of the brochure
will be given to each woman at the time of recruitment.
Women will be given the opportunity to read the informa-
tion sheet, think about the study, and then consent if they
wish.
Informed consent
Written consent will be obtained if a woman agrees to
enter the study. This will be witnessed and signed by
another person, as well as the research midwife.
Assessment of eligibility
Research midwives will liaise with midwifery and clerical
staff in the antenatal clinics to obtain daily booking visit
lists. A preliminary assessment of a woman's study eligi-
bility will be made by checking the woman's medical
record.
Recruitment protocol
Women will be approached prior to or immediately after
completion of the midwife booking visit. Research mid-
wives will follow a recruitment guide after determining
that a woman is potentially eligible.
Table 1: Power calculations with n = 904** in each arm
Outcome Standard care Caseload Power to detect specified difference
%%
Birth by caesarean section 19 14 80
Instrumental vaginal birth 10.6 6.6 84
Epidural analgesia 18 13 82
Intact perineum or unsutured laceration (increase)* 41.2 48.2 84
Intact perineum or unsutured laceration (decrease)* 41.2 34.2 86
3rd or 4th degree laceration* (would not miss this difference) 1.7 3.4 57
Induction of labour 27 21 84
Augmentation of labour 19 14 80
Exclusive breastfeeding at 6 months 8 12 79
Any breastfeeding at 6 months 53 63 99
Postnatal depression at 8 weeks 15 10 88
Postnatal depression at 6 months 15 10 88
Smoking at time of birth 15 10 88
*These estimations exclude caesarean births
** Allows for loss to follow-upBMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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If a woman does not wish to decide immediately, she will
be provided with study contact details, a copy of the con-
sent form and background questionnaire, and a reply paid
envelope. To join the study she can then contact the
research midwife and return the forms by mail. Upon the
return of the forms, the woman will be randomised and
contacted regarding the outcome of the random alloca-
tion.
Intervention allocation
Randomisation procedure
The randomisation system in use for the trial was devel-
oped by the Australian National Health and Medical
Research Centre Clinical Trials Centre http://
www.ctc.usyd.edu.au. An Interactive Voice Response Sys-
tem (IVRS) activated by telephone will be used for ran-
domising women to the two treatment arms of the trial
(i.e. standard care and caseload midwifery care).
Randomisation will be undertaken using stratified per-
muted blocks of varying size, with randomisation strati-
fied by parity (i.e. first or subsequent birth). For each
woman, the system will assign the treatment in the next
available sequential slot in the appropriate list of blocks.
When a woman agrees to enter the study the research mid-
wife will complete a COSMOS study specific Trial Ran-
domisation IVRS Worksheet with details that the system
will request to complete the randomisation procedure
(e.g. woman's full initials, parity and date of birth). Access
to the IVRS is achieved by dialing a toll-free telephone
number and navigating to the COSMOS trial via a menu
system. The system is designed so that no woman can be
randomised twice. A back-up system is in place in case of
a system failure, via a nominated person at the Clinical
Trial Centre. After completing all prompts the woman will
be allocated a study number and treatment arm. The
woman will be informed immediately of the randomisa-
tion outcome and further maternity care bookings
arranged accordingly.
Study participation
Baseline
After consenting to participate in the study and prior to
randomisation, women will be asked to complete a base-
line questionnaire, which includes demographic data.
Intervention
Women will be allocated to either the control or interven-
tion arms (described below).
Follow-up
Further data collection is scheduled to take place follow-
ing the birth (obstetric and medical data obtained from
hospital record) and self-completed participant question-
naires at two and six months postpartum (postal). The
hospital records will be checked following the birth before
sending postal questionnaires to minimise the chance of
a woman who has experienced a fetal death or an early
neonatal death receiving a questionnaire. Women who
are seriously ill or who have had a seriously ill infant will
be sent questionnaires subject to confirmation that they
have been discharged from hospital in good health.
Where there are any concerns regarding whether a woman
should be sent a questionnaire, the research team will dis-
cuss the issue and reach agreement.
Study completion
Successful completion of the study occurs after the six-
month questionnaire is returned. If desired, women will
be sent a summary of the results after completion of the
analyses.
Participant discontinuation
Women are free to withdraw from the study at any time.
No further study follow-up will occur.
Interventions
Description of caseload care
Women allocated to the caseload intervention will receive
antenatal, intrapartum and postpartum care from a pri-
mary caseload midwife with one or two antenatal visits to
be conducted by a 'back-up' midwife. The primary mid-
wife will be on call for the woman's labour and birth
except in designated circumstances such as annual leave;
sick leave; having already worked more than 12 hours in
a 24 hour period; having more than one woman in
labour; or if it is on one of the two days per week that the
primary midwife is scheduled to not work or be on call.
Care will then be provided by a back-up midwife or on
occasion by non-caseload midwives. Negotiation of these
details will be organised within each caseload group, as
autonomy and control over working times and conditions
have been shown to be important aspects of preventing
burnout [24]. The primary midwife will collaborate with
obstetricians and other health professionals as necessary,
and will continue to provide caseload care in addition to
care provided by obstetricians if complications develop.
In addition to providing care until after the birth of the
baby, the primary midwife (or a back up midwife) will
attend the hospital on most days to provide some postna-
tal care and will provide domiciliary care following dis-
charge from hospital. Care will be provided according to
hospital guidelines and protocols.
Recruitment of midwives to caseload
Approximately 12 fulltime midwives are required to staff
the intervention. This can consist of more actual midwives
(e.g. it could be several part time midwives). Positions will
be advertised in the first instance internally, then if theBMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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required number is not met there will be external adver-
tisements. To be eligible, midwives need to have com-
pleted two years clinical midwifery post-registration.
Education of caseload midwives
In addition to any education deemed to be necessary by
the hospital in preparation for working in the caseload
model, caseload midwives will be offered a one day train-
ing session by the research team. One third of the day will
focus on the research components of the trial and the rest
will be in regard to working in this new way-practicalities,
personal boundaries, and working in a small group (see
Additional file 2 for program outline).
Description of standard care
Women allocated to the control group can choose from
the standard hospital options for low risk women; these
include midwifery-led care – which may involve some
continuity or could mean women seeing a different mid-
wife for every visit; care by junior medical obstetric staff;
or community based care – usually shared care with an
accredited general medical practitioner (GP) (i.e. the GP
provides the majority of the woman's antenatal care, usu-
ally nearer to her home, but the woman is booked for
labour, birth and postnatal care at the hospital). In both
the midwife-led and GP-led models women would be
booked to see an obstetrician at 36 and 42 weeks gesta-
tion, with other referral or consultation as necessary.
When women come into the hospital for labour, birth and
postnatal care they will be cared for by whichever mid-
wives and doctors are rostered for duty. Care will be pro-
vided according to the same hospital guidelines and
protocols as for the women in the intervention arm.
It is possible that some women allocated to either the
intervention or the control group will seek other care
options, such as care with a private obstetrician or mid-
wife, but neither of these is available at the Royal
Women's Hospital. In this event we aim to obtain all data
as planned, and analysis will be by intention-to-treat.
Process evaluation
Adherence to the study protocol will be monitored and
intervention fidelity measured in a range of ways.
Measures of intervention exposure
Data regarding the extent to which care was provided by
the primary midwife will be collected from the medical
record following the birth and from the women via postal
questionnaire at two months. To assess and compare con-
tinuity of carer, women in both trial arms will be asked
about the presence of known care providers for labour,
birth, postnatal hospital care and domiciliary care.
Caseload midwife meetings
Monthly team meetings will be held with the caseload
midwives and a member of the research team (DF) to pro-
vide support and give an opportunity for problem-solving
and debriefing. The research team member will be availa-
ble to the caseload midwives before and after meetings
and will be contactable between meetings by email or tel-
ephone. Protocol adherence will be discussed at team
meetings. Other key support for the caseload midwives
will be from their clinical manager(s) as well as from the
Director of Maternity Services (TF).
Adherence to protocols
Three sources will contribute to assessing adherence to the
intervention protocols: interviews with the intervention
midwives at the beginning and end of the trial; monthly
meetings between the caseload midwives and the research
team member; and data collection from the medical
records.
Intervention evaluation by participants
The postal questionnaire sent to women at two months
will include a number of questions about women's model
of care and continuity of carer. Questions will also assess
satisfaction with model of care provision.
Intervention evaluation by caseload midwives, non-caseload midwives 
and other key stakeholders
Comprehensive evaluation of how the intervention works
within the organisation will be undertaken using surveys
and key informant interviews.
Data collection
Trial participants
❍ A background demographic data questionnaire will be
completed by women at the time of recruitment, prior to
randomisation.
❍ Obstetric/medical data will be collected manually from
the medical record following the birth.
❍ Data will be collected at two and six months postpar-
tum by postal survey. Questionnaires will be mailed by
the research midwives and/or project coordinator. A cov-
ering letter will be sent with each questionnaire and a
reply paid envelope included. To maximise response, a
reminder letter will be sent two weeks after the first mail-
ing, then if there is no response in another two weeks
women will receive a second reminder letter that includes
another copy of the questionnaire. When these question-
naires are returned they will be checked for women's
responses to the self harm question (Q10) on the Edin-
burgh Postnatal Depression Scale [49], and if a woman
has indicated that the thought about harming herself has
occurred to her "quite often" in the last week she will beBMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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telephoned according to a pre-specified protocol (see
Additional file 3).
Caseload midwives, non-caseload midwives and other key 
stakeholders
❍ A questionnaire will be administered to all caseload
midwives and non-caseload midwives near the beginning
and at completion of the trial. In-depth interviews will
also be conducted with all caseload midwives and a sam-
ple of non-caseload midwives and other key stakeholders,
near the beginning of the trial and on completion. These
will be audio-taped then transcribed verbatim.
❍ Midwife retention rates for caseload midwives and non-
caseload midwives will be estimated at baseline and post-
trial to enable a comparison.
❍ Logs of caseload midwives' time spent on their various
work tasks will be collected for several one-month inter-
vals throughout the trial.
Economic evaluation
❍ Resource use data will be collected from the medical
record following birth and from women's self-reported
use of health care and other resources in the six months
after birth, via the postal questionnaires at two and six
months postpartum.
Data coding
Data coding schedules have been devised for each survey
questionnaire, and coding will be undertaken as the ques-
tionnaires are returned.
Data management
Data storage
Data will be stored in locked filing cabinets in locked
rooms and accessed only by the project coordinator and
chief investigators. Computer files will be password pro-
tected and will be accessed only by the project coordinator
and chief investigators. Data linking women's names and
study ID will be kept on a separate database to women's
questionnaires which will be identified by study ID only.
Data entry
Survey data will be entered by a professional data entry
company then the files exported to an Access database
[50].
Qualitative data entry: open-ended questions from the
surveys will be entered by the project coordinator. Key
informant interviews will be transcribed verbatim by an
external professional transcriber. Analysis will be under-
taken by members of the research team.
Data cleaning
Data cleaning for quantitative data will be undertaken
using a variety of approaches including range and logical
checks, first in Access [50] then again when the data is
transferred to the statistical software package STATA [51].
Data analysis
Quantitative analysis
This will be undertaken using STATA [51] and data will be
collected to meet the CONSORT guidelines for reporting
of randomised trials.
The first stage of analysis will check the comparability of
participants allocated to the two groups. The intervention
group will be compared with the standard care group by
intention to treat analysis. Proportions of women having
a caesarean section will be compared using chi-square
tests and odds/risk ratios. Comparison of means will be
undertaken for continuous variables using t-tests where
data are normally distributed or medians compared using
Mann-Whitney U tests otherwise. Ranked or Likert-type
scales will be analysed using cumulative odds ratios.
Where there are differences in baseline characteristics of
the women in the two groups which might be associated
with outcomes, an additional multivariate analysis will be
carried out.
Qualitative analysis
Analysis of open-ended questions from surveys will be
undertaken using simple thematic analysis and coded into
themes. Key informant interviews will be transcribed ver-
batim and the transcripts checked against the audiotape
for accuracy. A thematic network will be constructed using
electronic and paper copies of the transcripts from the
interviews, as a way of organising the thematic analysis,
providing emerging basic, organising, and global themes
to describe the data [52]. Transcripts will be read and
reread to gain an overall perspective then a step by step
approach used. A coding framework will be developed to
reduce the text to meaningful manageable parts. Basic
emerging themes will be identified, then summarised into
more abstract groups (organising themes) and finally
summarised as overriding metaphors, or global themes
[52].
Study administration
Personnel
Principal investigators
Dr. Helen McLachlan (Mother and Child Health Research
& Division of Nursing & Midwifery, La Trobe University)
Dr. Della Forster (Mother and Child Health Research, La
Trobe University & Royal Women's Hospital)BMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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Ms. Mary-Ann Davey (Mother and Child Health Research,
La Trobe University & Consultative Council on Obstetric
and Paediatric Mortality and Morbidity (CCOPMM), Vic-
torian Department of Human Services)
Professor Judith Lumley (Mother and Child Health
Research, La Trobe University)
Ms Tanya Farrell (Royal Women's Hospital)
Professor Jeremy Oats (initially Royal Women's Hospital,
later CCOPMM, Victorian Department of Human Serv-
ices)
Ms. Lisa Gold (Deakin University)
Professor Ulla Waldenström (Karolinska Institutet, Stock-
holm)
Associate investigators
Dr. Mary Anne Biro (Mother and Child Health Research,
La Trobe University)
Professor Leah Albers (University of New Mexico, USA)
Project team
Helen McLachlan
Della Forster
Mary-Ann Davey
Judith Lumley
Tanya Farrell
Mary Anne Biro
Lisa Gold
Michelle Newton
Project coordinator
Mary Anne Biro
Research midwives
Michelle Kealy
Sue Veljanovski
Jo Rayner
Cath Fitzsimon
Health economics research assistant
Bree Rankin
Job descriptions of required personnel
Position descriptions: Project coordinator; Research Mid-
wife and Health economics research assistant (see Addi-
tional file 4)
Staff education
Research midwives will be required to undertake one day
of initial orientation regarding the project overall, includ-
ing the data collection tools, the recruitment process and
interview techniques. This process will continue with
supervised recruitment, and then continued close contact
by the project coordinator.
Staff meetings
It is anticipated that the research project team will meet
monthly throughout the project, and more often as neces-
sary.
Study reference group
A reference group will be established to bring together a
group of people from a range of backgrounds, with rele-
vant expertise and interest in the trial. They will contribute
ideas and advice to the research team through all stages of
the project; comment on drafts of materials and resources
developed to support the project (e.g. questionnaires);
provide advice and assistance in promoting the project
where appropriate; participate in discussion of the find-
ings and their implications for health service delivery
across Victoria and assist in developing appropriate strat-
egies for disseminating the findings of the project. Terms
of reference have been developed (see Additional file 5).
Responsibility for conduct of the study remains with the
principal investigators.
Timelines
This trial is expected to take four years which includes
recruitment of 85 women per month, requiring 24
months for recruitment. Medical data will be collected
shortly after the birth, then a postal questionnaire will be
mailed to women at two and six months postpartum. Fol-
lowing recruitment of the final woman to the study, it will
take 14 months to complete data collection. The fourth
year will be required to finalise data collection and analy-
sis.
Documents required
Information brochure
An information brochure will be sent to all women when
they ring and book into the hospital and will also be given
to women at recruitment (see Additional file 1).BMC Pregnancy and Childbirth 2008, 8:35 http://www.biomedcentral.com/1471-2393/8/35
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Participant information
Eligible women who are approached to participate in the
study will be given a participant information sheet.
Consent form
Written consent will be obtained if the woman agrees to
enter the study. This will be witnessed by another person
as well as the research midwife.
Data collection forms/software
- Background demographic questionnaire
- Two month questionnaire
- Six month questionnaire
- Medical/obstetric outcome collection form
- Daily recruitment figures form
- Excel workbook to track recruitment and record data
related to population numbers, proportion approached
and consented, and reasons for non-participation [53]
- Access database to track participants [50]
- Staff surveys at start and end of trial
Coding schedules
Coding schedules for each data collection form.
Ethical considerations
Ethics approvals
Approvals were received from
Research and Ethics Committees, Royal Women's Hospi-
tal (No. 07/01)
University Human Ethics Committee, La Trobe University
(No. 07-04)
Informed written consent
Written consent will be obtained if a woman agrees to
enter the study. This will be witnessed by another person,
as well as the research midwife. Written consent will also
be obtained from all staff members who are offered and
agree to an in-depth interview and from all caseload mid-
wives who agree to participate in the various aspects of
data collection pertaining to them.
Risks/inconvenience/benefits
We do not anticipate any potential or actual harms of par-
ticipation. Many RCTs of continuity of midwifery care
compared with standard medical care have reported no
statistically significant differences in perinatal morbidity
or mortality and have reported increased satisfaction with
care in the continuity of midwifery arm. The model to be
trialed focuses much more on continuity of carer rather
than continuity by a team of carers, and thus benefits or
potential harms will not be known until results are avail-
able.
This study includes women who are at low medical risk
and excludes women at high risk. A strict protocol will be
followed for women who develop complications. If a
woman in the intervention arm develops medical or
obstetric complications she will be transferred to medical
care as per the hospital protocol, but in addition will con-
tinue to receive caseload midwifery care.
There is evidence from RCTs that continuity of midwifery
care may lead to reduced caesarean sections and operative
vaginal births, and a decrease in other interventions in
labour including induction, augmentation, analgesia use
and episiotomy.
Data monitoring and safety committees
A data monitoring committee will be established compris-
ing an external statistician, a clinical expert and an expert
in RCTs to check the randomisation and undertake an
interim analysis. A safety committee, including members
with relevant expertise, who are blinded to group alloca-
tion, will be established to review reports of any adverse
events. Additional file 5 includes the terms of reference for
these committees.
Interim analysis
The data monitoring committee will conduct an interim
analysis on the medical/obstetric outcome data and
recruitment rate when 500 births have occurred in each
arm of the trial.
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